Global Vaccine Action Plan lessons learned III: Monitoring and evaluation/accountability framework.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
14 07 2020
Historique:
received: 24 02 2020
revised: 06 05 2020
accepted: 09 05 2020
pubmed: 21 5 2020
medline: 28 4 2021
entrez: 21 5 2020
Statut: ppublish

Résumé

The Monitoring & Evaluation/Accountability (M&E/A) framework of the Global Vaccine Action Plan (GVAP) was used to report progress annually to the World Health Assembly (WHA). Stakeholder feedback was obtained through five reviews consisting of surveys and semi-structured interviews conducted from 2017 to 2019. Participants consisted of individuals involved in the development and implementation of GVAP or its M&E/A process, national immunization managers, academics, representatives of non-governmental organizations, and civil society organizations. The feedback was mixed and contradictory for some components, though most participants reported that the M&E/A process was a highlight of GVAP and a step in the right direction. Several of the goals and targets were considered aspirational and unrealistic for many countries. There were mixed responses on whether it promoted accountability, especially at the country level. The mixed and contradictory views on the M&E/A processes and its impact suggested a failure of communication about its scope and intent. Though the process, especially the annual reporting to the WHA, kept immunization high on the global agenda, it failed to fully meet the expectations in promoting accountability. Engaging with countries to capture the local context in setting global goals and targets and promoting local M&E/A processes will be important to achieve accountability in the next decade.

Identifiants

pubmed: 32430149
pii: S0264-410X(20)30647-2
doi: 10.1016/j.vaccine.2020.05.028
pmc: PMC7342004
pii:
doi:

Substances chimiques

Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5379-5383

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Vaccine. 2020 Jul 14;38(33):5372-5378
pubmed: 32505440

Auteurs

Thomas Cherian (T)

MMGH Consulting GmbH, Kuerbergstrasse 1, 8049 Zurich, Switzerland. Electronic address: cheriant@mmglobalhealth.org.

Angela Hwang (A)

MMGH Consulting GmbH, Kuerbergstrasse 1, 8049 Zurich, Switzerland; Angela Hwang Consulting, P.O. Box 6601, Albany, CA 94706, USA. Electronic address: angela@ahwang.net.

Carsten Mantel (C)

MMGH Consulting GmbH, Kuerbergstrasse 1, 8049 Zurich, Switzerland. Electronic address: mantelc@mmglobalhealth.org.

Chantal Veira (C)

Task Force for Global Health, 330 West Ponce de Leon Ave., Decatur, GA 30030, USA. Electronic address: cveira@taskforce.org.

Stefano Malvolti (S)

MMGH Consulting GmbH, Kuerbergstrasse 1, 8049 Zurich, Switzerland. Electronic address: malvoltis@mmglobalhealth.org.

Noni MacDonald (N)

Dalhousie University, IWK Health Centre, Halifax, Canada.

Christoph Steffen (C)

World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland. Electronic address: steffenc@who.int.

Ian Jones (I)

Jinja Publishing Ltd, Bishop's Stortford, United Kingdom.

Alan Hinman (A)

Task Force for Global Health, 330 West Ponce de Leon Ave., Decatur, GA 30030, USA. Electronic address: ahinman@taskforce.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH